Amedisys 미래 성장

Future 기준 확인 3/6

Amedisys (는) 각각 연간 28.9% 및 6.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 28.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 12.5% 로 예상됩니다.

주요 정보

28.9%

수익 성장률

28.9%

EPS 성장률

Healthcare 수익 성장	27.3%
매출 성장률	6.4%
향후 자기자본 수익률	12.5%
애널리스트 커버리지	Good
마지막 업데이트	14 Oct 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

BMV:AMED * - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	2,702	173	N/A	N/A	2
12/31/2025	2,513	167	189	196	11
12/31/2024	2,347	126	170	176	12
6/30/2024	2,290	92	88	96	N/A
3/31/2024	2,251	-21	91	105	N/A
12/31/2023	2,236	-10	124	137	N/A
9/30/2023	2,228	3	105	118	N/A
6/30/2023	2,229	2	101	114	N/A
3/31/2023	2,234	112	103	111	N/A
12/31/2022	2,223	119	126	133	N/A
9/30/2022	2,220	121	91	98	N/A
6/30/2022	2,216	140	166	173	N/A
3/31/2022	2,222	191	177	184	N/A
12/31/2021	2,214	209	182	189	N/A
9/30/2021	2,206	220	242	250	N/A
6/30/2021	2,196	247	264	271	N/A
3/31/2021	2,117	202	331	337	N/A
12/31/2020	2,072	184	284	289	N/A
9/30/2020	2,021	166	294	298	N/A
6/30/2020	1,972	128	256	263	N/A
3/31/2020	1,980	127	180	188	N/A
12/31/2019	1,956	127	194	202	N/A
9/30/2019	1,889	127	184	191	N/A
6/30/2019	1,812	124	204	212	N/A
3/31/2019	1,731	123	197	203	N/A
12/31/2018	1,663	119	217	223	N/A
9/30/2018	1,626	88	184	192	N/A
6/30/2018	1,583	71	128	133	N/A
3/31/2018	1,546	42	N/A	119	N/A
12/31/2017	1,511	30	N/A	106	N/A
9/30/2017	1,474	43	N/A	102	N/A
6/30/2017	1,456	40	N/A	99	N/A
3/31/2017	1,438	46	N/A	77	N/A
12/31/2016	1,419	37	N/A	62	N/A
9/30/2016	1,391	41	N/A	54	N/A
6/30/2016	1,358	38	N/A	78	N/A
3/31/2016	1,313	38	N/A	106	N/A
12/31/2015	1,266	-3	N/A	108	N/A
9/30/2015	1,230	-7	N/A	92	N/A
6/30/2015	1,204	-7	N/A	87	N/A
3/31/2015	1,193	-10	N/A	-45	N/A
12/31/2014	1,188	13	N/A	-66	N/A
9/30/2014	1,191	-4	N/A	-62	N/A
6/30/2014	1,192	-103	N/A	-59	N/A
3/31/2014	1,203	-109	N/A	64	N/A
12/31/2013	1,233	-93	N/A	102	N/A

애널리스트 미래 성장 예측

수입 대 저축률: AMED * 의 연간 예상 수익 증가율( 28.9% )이 saving rate( 7.9% 보다 높습니다. ).

수익 vs 시장: AMED * 의 연간 수익( 28.9% ) MX 시장( 11.3% 보다 빠르게 성장할 것으로 예상됩니다. 11.3% 연간).

고성장 수익: AMED * 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: AMED * 의 수익(연간 6.4% ) MX 시장( 7.1% 보다 느리게 성장할 것으로 예상됩니다. 7.1% 연간).

고성장 수익: AMED * 의 수익(연간 6.4% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: AMED * 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 12.5 %).

Amedisys 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Amedisys, Inc. Provides Earnings Guidance for the Year 2022

Amedisys, Inc. Provides Revenue Guidance for the Full Year 2021

Recent updates

Michael P. North Leaves Amedisys, Inc. as Chief Information Officer and Compensation Committee of the Board of Directors, Effective August 31, 2024

Insufficient new directors

Option Care Health, Inc. (NasdaqGS:OPCH) cancelled the acquisition of Amedisys, Inc. (NasdaqGS:AMED).

Option Care Health, Inc. (NasdaqGS:OPCH) entered into an agreement and plan of merger to acquire Amedisys, Inc. (NasdaqGS:AMED) for $3.2 billion.

Insufficient new directors

Amedisys, Inc. (NasdaqGS:AMED) announces an Equity Buyback for $100 million worth of its shares.

Amedisys, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Insufficient new directors

Insufficient new directors

Amedisys, Inc. Names Scott Ginn as Acting Chief Operating Officer

Amedisys, Inc. Announces CEO Changes

Amedisys, Inc. Provides Earnings Guidance for the Year 2022

Amedisys, Inc. to Report Q3, 2022 Results on Oct 26, 2022

Investor sentiment deteriorated over the past week

High number of new directors

Amedisys, Inc. Announces Resignation of David L. Kemmerly as Chief Legal and Government Affairs Officer

Second quarter 2022 earnings released: EPS: US$0.91 (vs US$2.46 in 2Q 2021)

High number of new directors

Amedisys, Inc. to Report Q2, 2022 Results on Jul 27, 2022

Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 1000 Growth-Defensive Index

High number of new directors

Investor sentiment deteriorated over the past week

High number of new directors

Amedisys, Inc. Announces Promotion of Nick Muscato as Chief Strategy Officer

Amedisys, Inc. to Report Q1, 2022 Results on Apr 27, 2022

Amedisys, Inc. (NasdaqGS:AMED) completed the acquisition of Assets of AssistedCare Home Health, Inc. and RH Homecare Services, LLC.

High number of new directors

Amedisys, Inc. Announces Resignation of Richard A. Lechleiter from the Board of Directors

Investor sentiment improved over the past week

High number of new directors

Amedisys, Inc. (NasdaqGS:AMED) signed a definitive agreement to acquire Assets of AssistedCare Home Health, Inc.

Amedisys, Inc. (NasdaqGS : AMED) agreed to acquire Evolution Health, LLC from Emergency Medical Services LP Corporation.

Amedisys, Inc. to Report Q4, 2021 Results on Feb 23, 2022

High number of new directors

Investor sentiment deteriorated over the past week

Lead Independent Director recently bought Mex$3.0m worth of stock

Third quarter 2021 earnings released: EPS US$1.38 (vs US$2.20 in 3Q 2020)

Investor sentiment improved over the past week

High number of new directors

High number of new directors

Independent Director recently sold Mex$42m worth of stock

Second quarter 2021 earnings released: EPS US$2.46 (vs US$1.07 in 2Q 2020)

Investor sentiment deteriorated over the past week

High number of new directors

President & COO recently sold Mex$1.5m worth of stock

Amedisys, Inc. (NasdaqGS:AMED) entered into an Agreement to acquire Contessa Health, Inc. for $250 million.

Amedisys, Inc. (NasdaqGS:AMED) entered into a definitive agreement to acquire Home Health and Hospice Operations of Visiting Nurse Association.

Insider recently sold Mex$10m worth of stock

Amedisys, Inc. Provides Revenue Guidance for the Full Year 2021

First quarter 2021 earnings released: EPS US$1.52 (vs US$0.98 in 1Q 2020)

Amedisys, Inc. and Sound Physicians to Launch Home Health Advanced Pilot Program

Independent Director recently bought Mex$5.3m worth of stock

Revenue misses expectations

Full year 2020 earnings released: EPS US$5.64 (vs US$3.95 in FY 2019)

Amedisys, Inc. Announces Executive Changes

Amedisys, Inc. Announces Executive Changes

Amedisys, Inc. to Report Q4, 2020 Results on Feb 24, 2021

Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 2000 Dynamic Index

Amedisys, Inc. and Option Care Health Inc. Collaborate to Provide Innovative COVID Therapy Access Model

Ivanetta Davis Samuels Joins Amedisys, Inc.'s Board of Director

Amedisys, Inc. to Report Q3, 2020 Results on Oct 28, 2020

Amedisys, Inc. to Report Q2, 2020 Results on Jul 28, 2020

Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 2000 Growth-Defensive Index

Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 2000 Defensive Index

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견